RYSPX
Price
$100.71
Change
+$0.52 (+0.52%)
Updated
Oct 17 closing price
Net Assets
160.52M
VTSAX
Price
$159.29
Change
+$0.70 (+0.44%)
Updated
Oct 17 closing price
Net Assets
2.02T
Interact to see
Advertisement

RYSPX vs VTSAX

Header iconRYSPX vs VTSAX Comparison
Open Charts RYSPX vs VTSAXBanner chart's image
Rydex S&P 500 H
Price$100.71
Change+$0.52 (+0.52%)
VolumeN/A
Net Assets160.52M
Vanguard Total Stock Mkt Idx Adm
Price$159.29
Change+$0.70 (+0.44%)
VolumeN/A
Net Assets2.02T
RYSPX vs VTSAX Comparison Chart in %
View a ticker or compare two or three
VS
RYSPX vs. VTSAX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYSPX is a Hold and VTSAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 2.02T vs. RYSPX (161M). VTSAX pays higher dividends than RYSPX: VTSAX (1.13) vs RYSPX (0.13). RYSPX was incepted earlier than VTSAX: RYSPX (19 years) vs VTSAX (25 years). RYSPX (1.65) is less costly to investors than VTSAX (0.04). RYSPX is a more actively managed with annual turnover of: 137.00 vs. VTSAX (2.00). RYSPX has a lower initial minimum investment than VTSAX: RYSPX (2500) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 13.27 vs. RYSPX (12.05). VTSAX return over 5 years is better than : 84.09 vs. RYSPX (59.90).
RYSPXVTSAXRYSPX / VTSAX
Total Expense Ratio1.600.044,000%
Annual Report Gross Expense Ratio1.650.044,125%
Fund Existence19 years25 years-
Gain YTD12.38412.52699%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets161M2.02T0%
Annual Yield % from dividends0.131.1312%
Returns for 1 year12.0513.2791%
Returns for 3 years74.6377.3996%
Returns for 5 years59.9084.0971%
Returns for 10 years147.29223.9766%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FDMT10.090.13
+1.31%
4D Molecular Therapeutics
NVVE0.23N/A
+0.44%
Nuvve Holding Corp
ADAG1.78-0.01
-0.56%
Adagene
CRS238.12-4.06
-1.68%
Carpenter Technology Corp
PGY27.70-2.21
-7.39%
Pagaya Technologies Ltd